Loading company
Latest annual · FY2018
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (2)
Latest quarter · Q2 FY2024
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
Biostax Corp. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.5 million | -$1.2 million | 10-K 2024-04-16 · proof | |
| Net income | -$2.4 million | -$3.5 million | 10-K/A 2024-07-05 · proof | |
| Cash from operating activities | -$408,026 | -$581,821 | 10-K/A 2024-07-05 · proof | |
| Total assets | $35,285 | $963,719 | -96.3% | 10-Q 2024-05-20 · proof |
| Total liabilities | $4.6 million | $3.5 million | +31.2% | 10-K/A 2024-07-05 · proof |
| Cash and cash equivalents | $35,285 | $150,491 | -76.6% | 10-Q 2024-08-19 · proof |
- What was Biostax Corp.'s operating income in fiscal 2023?
- Biostax Corp. reported operating income of -$1.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was Biostax Corp.'s net income in fiscal 2023?
- Biostax Corp. reported net income of -$2.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$3.5 million the year before. Source: the 10-K/A filed with the SEC on Jul 5, 2024 (restated). SEC
- What was Biostax Corp.'s cash from operating activities in fiscal 2023?
- Biostax Corp. reported cash from operating activities of -$408,026 for fiscal 2023 (the year ended Dec 31, 2023), against -$581,821 the year before. Source: the 10-K/A filed with the SEC on Jul 5, 2024 (restated). SEC
- What are Biostax Corp.'s total assets?
- As of Dec 31, 2023, Biostax Corp. reported total assets of $35,285, against $963,719 a year earlier (-96.3%). Source: the 10-Q filed with the SEC on May 20, 2024 (restated). SEC
- What are Biostax Corp.'s total liabilities?
- As of Dec 31, 2023, Biostax Corp. reported total liabilities of $4.6 million, against $3.5 million a year earlier (+31.2%). Source: the 10-K/A filed with the SEC on Jul 5, 2024 (restated). SEC
- What are Biostax Corp.'s cash and cash equivalents?
- As of Dec 31, 2023, Biostax Corp. reported cash and cash equivalents of $35,285, against $150,491 a year earlier (-76.6%). Source: the 10-Q filed with the SEC on Aug 19, 2024 (restated). SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1559356&period_type=annual&limit=5"Information only, not investment advice.